» Articles » PMID: 19130316

Community-based Study of the Association of Subclinical Thyroid Dysfunction with Blood Pressure

Overview
Journal Endocrine
Specialty Endocrinology
Date 2009 Jan 9
PMID 19130316
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between subclinical thyroid dysfunction and blood pressure has been controversial and received unsufficient attention. Thus, we performed a cross-sectional study conducted among 6,992 inhabitants from six districts of Jiangsu Province to investigate the association of subclinical thyroid dysfunction with blood pressure in China. The data from 6,583 subjects (4,115 women and 2,468 men) were included and divided into three groups: euthyroidism (n = 5669, 86.11%), subclinical hyperthyroidism (n = 108, 1.65%), and subclinical hypothyroidism (n = 806, 12.24%). In the groups with subclinical hypothyroidism and hyperthyroidism, systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure were not significantly different from those in the groups with euthyroidism after being adjusted for age, sex, BMI, and smoking status (P > 0.05). More extensively, the SBP and DBP in the group of subclinical hypothyroidism with lower level of TSH (TSH 4.51-10.00 mIU/l, SCH(1)) were significantly higher than those of participants with euthyroidism (P < 0.05). Multivariable logistic analysis revealed that subclinical hypothyroidism with lower TSH (TSH 4.51-10.00 mIU/l) was an independent risk factor for increased SBP (OR = 1.28, 95% CI 1.03-1.59, P = 0.028). Similar results could not be found between groups of euthyroid and subclinical hypothyroid with higher level of TSH (TSH > 10 mIU/l, SCH(2)). Further subdivision of the euthyroid group on the basis of a TSH cut-off of 2.5 mIU/l, revealed still no significant difference in blood pressure after adjustment regardless of whether the TSH levels were in the lower reference (TSH 0.40-2.50 mIU/l, n = 4093) or in the upper reference ranges (TSH 2.51-4.50 mIU/l, n = 1576) (P > 0.05). We concluded that subclinical thyroid dysfunction was not associated with blood pressure. Neither subclinical hyperthyroidism nor subclinical hypothyroidism independently predicted increased blood pressure.

Citing Articles

Association between blood lead levels and metabolic syndrome considering the effect of the thyroid-stimulating hormone based on the 2013 Korea National health and nutrition examination survey.

Choi J, Huh D, Moon K PLoS One. 2020; 15(12):e0244821.

PMID: 33382832 PMC: 7775085. DOI: 10.1371/journal.pone.0244821.


Gender-Specific Differences on the Association of Hypertension with Subclinical Thyroid Dysfunction.

Zhang J, Huang C, Meng Z, Fan Y, Yang Q, Zhang W Int J Endocrinol. 2020; 2019:6053068.

PMID: 32082373 PMC: 7012202. DOI: 10.1155/2019/6053068.


Hypertension in Thyroid Disorders.

Berta E, Lengyel I, Halmi S, Zrinyi M, Erdei A, Harangi M Front Endocrinol (Lausanne). 2019; 10:482.

PMID: 31379748 PMC: 6652798. DOI: 10.3389/fendo.2019.00482.


In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and....

Morini E, Catalano A, Lasco A, Morabito N, Benvenga S Endocrine. 2019; 65(3):569-579.

PMID: 30919287 DOI: 10.1007/s12020-019-01908-x.


L-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia.

Morini E, Catalano A, Lasco A, Morabito N, Benvenga S Endocrine. 2018; 64(2):284-292.

PMID: 30368654 DOI: 10.1007/s12020-018-1798-7.


References
1.
Dorr M, Wolff B, Robinson D, John U, Ludemann J, Meng W . The association of thyroid function with cardiac mass and left ventricular hypertrophy. J Clin Endocrinol Metab. 2004; 90(2):673-7. DOI: 10.1210/jc.2004-1554. View

2.
Streeten D, Anderson Jr G, Howland T, CHIANG R, SMULYAN H . Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension. 1988; 11(1):78-83. DOI: 10.1161/01.hyp.11.1.78. View

3.
Volzke H, Alte D, Dorr M, Wallaschofski H, John U, Felix S . The association between subclinical hyperthyroidism and blood pressure in a population-based study. J Hypertens. 2006; 24(10):1947-53. DOI: 10.1097/01.hjh.0000244942.57417.8e. View

4.
Cappola A, Fried L, Arnold A, Danese M, Kuller L, Burke G . Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006; 295(9):1033-41. PMC: 1387822. DOI: 10.1001/jama.295.9.1033. View

5.
Ching G, Franklyn J, Stallard T, Daykin J, Sheppard M, Gammage M . Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart. 1996; 75(4):363-8. PMC: 484311. DOI: 10.1136/hrt.75.4.363. View